Omicron BA.4.6 Subvariant Spreading, May Evade Covid-19 Antibody Treatment In the week ending on October 8, the BA.4.6 Omicron subvariant constituted 13.6% of all tested Covid-19 samples in the U.S., up from 12.7% from the week prior.